European Union was Onconetix’s largest region in fiscal 2025, bringing in $587.88K of $625.44K (94%).
| Geography | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|
| European Union | $58.47K | $2.28M | $587.88K |
| United States | — | $63.12K | — |
| Switzerland | $58.47K | — | — |
| Non-European Union (Uk) | — | $23.84K | $18.78K |
| United Kingdom | — | $23.84K | $18.78K |
| Total | $116.93K | $2.39M | $625.44K |
Onconetix brought in $625.44K from its three regions in fiscal 2025, the year ended December 31, 2025. That is less than the $796.59K it reports by product and service, so these regions do not cover all of its revenue. European Union was the largest at $587.88K (94.0%), ahead of Non-European Union (Uk) at $18.78K (3.0%) and United Kingdom at $18.78K (3.0%).
Compared with fiscal 2024, every region above 2% of revenue shrank. Non-European Union (Uk) held up best, down 21.2% to $18.78K, and European Union fell the most, down 74.2% to $587.88K. Some of that change comes from Onconetix regrouping its regions.
Onconetix began breaking out Non-European Union (Uk) in fiscal 2024 and United Kingdom in fiscal 2024. Onconetix stopped reporting United States ($63.12K in fiscal 2024) and Switzerland ($58.47K in fiscal 2023) as separate regions.
Other Revenue was Onconetix’s largest product and service line in fiscal 2025, bringing in $587.88K of $796.59K (74%).
| Product and Service | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|
| Development Services | $58.47K | $2.28M | $1.65K |
| Other Revenue | — | — | $587.88K |
| Product Sales | — | $162.07K | $207.05K |
| License | — | — | $1 |
| Total | $58.47K | $2.44M | $796.59K |
Onconetix brought in $796.59K from its four product and service lines in fiscal 2025, the year ended December 31, 2025. Onconetix regrouped these lines after fiscal 2024, so the total does not compare directly with that year's $2.44M. Other Revenue was the largest at $587.88K (73.8%), ahead of Product Sales at $207.05K (26.0%) and Development Services at $1.65K (0.2%). The remaining line, License, brought in $1.
Onconetix began breaking out Other Revenue in fiscal 2025, Product Sales in fiscal 2024 and License in fiscal 2025.
Onconetix (ONCO) reports its revenue by geography and by product and service. In fiscal 2025, European Union was its largest region, bringing in $587.88K (94.0% of the total), followed by Non-European Union (Uk) at $18.78K (3.0%).
European Union was Onconetix's largest region in fiscal 2025, bringing in $587.88K, or 94.0% of the $625.44K total across its three regions.
Other Revenue was Onconetix's largest product and service line in fiscal 2025, bringing in $587.88K, or 73.8% of the $796.59K total across its four product and service lines.
Every figure comes from Onconetix's annual financial filings, as reported. Each line keeps the name Onconetix gives it, and years follow its fiscal calendar.
Onconetix's revenue by geography goes back to fiscal 2023, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.